Mark Perreault is Senior Director of Research & Development at Repligen Corp., a bioprocessing-focused life sciences company bringing expertise and innovation to customers since 1981. Mark earned his ...

Research recently published in Current Opinion in Chemical Engineering looked at challenges industry encounters when switching from batch to continuous-mode processes for mAb therapeutics and found ...